Loading...
NPI 1144327404 · Dubuque, IA · Long Term Care Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Hartig Drug Co Corp is a long term care pharmacy provider located in Dubuque, Iowa. This profile covers 8 Medicare and 8 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Hartig Drug Co Corp |
| Address | 7425 Chavenelle Rd |
| City | Dubuque |
| State | IA |
| ZIP | 52002 |
| Taxonomy | Long Term Care Pharmacy |
| NPI Enumerated | September 20, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $31.7K |
| Medicaid | $23.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 110 | $70 | $7.8K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 60 | $130 | $7.6K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 20 | $280 | $5.9K |
| G0008 | Administration of influenza virus vaccine | 190 | $30 | $5.2K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 60 | $40 | $2.2K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 80 | $20 | $1.7K |
| G0009 | Administration of pneumococcal vaccine | 20 | $30 | $700 |
| M0201 | Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s)… | 20 | $30 | $540 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.
View: State1 / 2
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 1,700 | $10 | $15.3K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 160 | $20 | $3.7K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 20 | $120 | $2K |
| A4259 | Lancets, per box of 100 | 800 | $1 | $800 |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 50 | $20 | $720 |
| G0008 | Administration of influenza virus vaccine | 50 | $10 | $510 |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 20 | $20 | $340 |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 10 | $10 | $130 |
How this provider's Medicaid billing volume and revenue compare to other Iowa providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Iowa median
8 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 8 | 10 | 530 | $90 | $275.7K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 38 | 280 | 390 | $20 | $21.1K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 367 | 520 | 100 | $10 | $6.1K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 42 | 60 | 30 | $70 | $4.2K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 83 | 120 | 30 | $20 | $1.6K |
| A4259 | Lancets, per box of 100 | 20 | 110 | 190 | $1 | $1.1K |
| G0008 | Administration of influenza virus vaccine | 39 | 140 | 30 | $10 | $630 |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 166 | 180 | 60 | $1 | $550 |
Other providers in the same ZIP code as Hartig Drug Co Corp, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Unified Therapy Services, Inc | IA | Physical Therapist | $0 | $11.1M |
| Medical Associates Clinic P C | IA | Multi-Specialty Clinic/Center | $0 | $6.4M |
| Tri-state Surgery Center, L.L.C. | IA | Ambulatory Surgical Clinic/Center | $2.3M | $0 |
| Peckosh Pediatric Dentistry, P.C. | IA | Dentist | $0 | $1.4M |
| Steven Leifker | IA | Pediatric Dentistry | $0 | $1.3M |
| Hills And Dales Child Development Center | IA | Behavior Analyst | $0 | $1.2M |
| Justin Risma | IA | Ophthalmology Physician | $377.5K | $0 |
| Juan Nieto | IA | Ophthalmology Physician | $279.9K | $0 |
| George Isaac | IA | Specialist | $251K | $0 |
| Jennifer Schope | IA | Dermatology Physician | $232.8K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.